RNAC icon

Cartesian Therapeutics
RNAC

Overview Fund Activity

64 hedge funds and large institutions have $66.3M invested in Cartesian Therapeutics in 2025 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 18 reducing their positions, and 13 closing their positions.

Holders
64
Holders Change
-8
Holders Change %
-11.11%
% of All Funds
0.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
22
Reduced
18
Closed
13
Calls
$149K
Puts
–
Net Calls
+$149K
Net Calls Change
+$149K

Top Buyers

1
6CM
1
683 Capital Management
New York
$2.28M
2
Marshall Wace
2
Marshall Wace
United Kingdom
$859K
3
Jacobs Levy Equity Management
3
Jacobs Levy Equity Management
New Jersey
$429K
4
GCP
4
GSA Capital Partners
United Kingdom
$432K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$203K

Top Sellers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$63.2K
2
MB
2
MPM BioImpact
Massachusetts
$7.13M
3
Citadel Advisors
3
Citadel Advisors
Florida
$1.26M
4
AA
4
ALPS Advisors
Colorado
$0
5
Goldman Sachs
5
Goldman Sachs
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
TWD
76
True Wealth Design
Ohio
– – -2 Closed
IA
77
IFP Advisors
Florida
– – -1 Closed
CA
78
CoreCap Advisors
Michigan
– – -1 Closed
Group One Trading
79
Group One Trading
Illinois
– – – –
1 2 3
4